AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Investors with deep pockets seek refuge in GDP Capital’s PE-BOND Fund amidst turbulent markets Key Investment Sectors KUALA LUMPUR, Malaysia, Jan. 09, 2024 (GLOBE NEWSWIRE) — The COVID-19 pandemic has unleashed unprecedented economic turmoil, resulting in contracting markets and dwindling returns worldwide. Private Equity and other investment sectors find themselves navigating an exceptionally challenging and […]
Read More »Apparel Group’s Announces New Record: Opens 350 New Stores in GCC & India, Forges 15 Strategic Global Brand Partnerships in 2023
Apparel Group’s Announces New Record: Opens 350 New Stores in GCC & India, Forges 15 Strategic Global Brand Partnerships in 2023 DUBAI, United Arab Emirates, Jan. 08, 2024 (GLOBE NEWSWIRE) — Marking a year of unprecedented growth and ground-breaking initiatives, Apparel Group stands at the pinnacle of retail innovation and global expansion in 2023. The […]
Read More »مجموعة أباريل تحقق أرقام قياسية بافتتاحها 350 متجراً في السوق الخليجي والهند وإتمام 15 شراكة استراتيجية دولية خلال عام 2023
مجموعة أباريل تحقق أرقام قياسية بافتتاحها 350 متجراً في السوق الخليجي والهند وإتمام 15 شراكة استراتيجية دولية خلال عام 2023 دبي, Jan. 08, 2024 (GLOBE NEWSWIRE) — كللت مجموعة أباريل عام 2023 بالتربع على قمة الابتكار والتوسع التجاري بتحقيقها لنمو غير مسبوق وقيادتها للعديد من المبادرات المحورية. واحتفلت الشركة في مقرها الرئيسي الواقع في دبي […]
Read More »ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EGRX
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) between August 8, 2023 and November 28, 2023, both dates inclusive (the “Class Period”). A class action […]
Read More »CMI INVESTOR ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cummins Inc. Investors to Inquire About Securities Class Action Investigation – CMI
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cummins Inc. (NYSE: CMI) resulting from allegations that Cummins may have issued materially misleading business information to the investing public. SO WHAT: If you purchased […]
Read More »ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages ACELYRIN, INC. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLRN
NEW YORK, Jan. 04, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ACELYRIN, INC. (NASDAQ: SLRN) between May 4, 2023 and September 11, 2023, both dates inclusive (the “Class Period”), of the important January 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased ACELYRIN […]
Read More »Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
Potential First-in-Class Novel Molecule with Novel Target In-Licensed from Collaboration with Bayer SALT LAKE CITY, Jan. 04, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has signed an agreement with Bayer AG to in-license a new chemical entity that emerged from […]
Read More »